Sampathkumar Krishnaswamy, Lobo Valentine, Balasubramaniam Jeyaraj, Mahaldar Amol, Yevzlin Alexander S, Kumbar Lalathaksha
Department of Nephrology, Meenakshi Mission Hospital and Research Centre, Madurai, Tamil Nadu, India; Department of Nephrology, KEM Hospital, Pune, Maharashtra, India; Department of Nephrology, Kidney Care Centre, Tirunelveli, Tamil Nadu, India; Department of Nephrology, Goa Medical College, Goa, India; Department of Nephrology, University of Wisconsin, Madison, WI; Department of Nephrology, Henry Ford Hospital, Detroit, MI.
Department of Nephrology, Meenakshi Mission Hospital and Research Centre, Madurai, Tamil Nadu, India; Department of Nephrology, KEM Hospital, Pune, Maharashtra, India; Department of Nephrology, Kidney Care Centre, Tirunelveli, Tamil Nadu, India; Department of Nephrology, Goa Medical College, Goa, India; Department of Nephrology, University of Wisconsin, Madison, WI; Department of Nephrology, Henry Ford Hospital, Detroit, MI.
Adv Chronic Kidney Dis. 2015 Nov;22(6):466-70. doi: 10.1053/j.ackd.2015.09.001.
India has one of the fastest growing economies in the world and is home to nearly one sixth of world's population. Chronic diseases such as diabetes mellitus and hypertension are common. Kidney disease is a known complication of these chronic diseases and is on the rise. Improving affordability with advanced care delivery has led to the increasing use of maintenance hemodialysis. Along with this hemodialysis comes the inevitable need for vascular access. Interventional nephrology in India is a fast-evolving discipline and promises to be a critical component of hemodialysis care in the future. This review provides a background on the current state of the CKD burden in India and the various vascular access options in use currently. In addition, we describe the experience of 2 centers in western and southern India in managing vascular access needs in hopes that they will serve as a model of the proliferation of vascular access care throughout India and in other developing countries.
印度是世界上经济增长最快的国家之一，拥有世界近六分之一的人口。糖尿病和高血压等慢性病很常见。肾脏疾病是这些慢性病的已知并发症，且呈上升趋势。先进的医疗服务提高了可及性，使得维持性血液透析的使用日益增加。随着血液透析的开展，对血管通路的需求也不可避免。印度的介入肾脏病学是一个快速发展的学科，有望成为未来血液透析治疗的关键组成部分。本综述提供了印度慢性肾脏病负担的现状以及目前使用的各种血管通路选择的背景信息。此外，我们描述了印度西部和南部两个中心在管理血管通路需求方面的经验，希望它们能成为印度及其他发展中国家血管通路护理普及的典范。
